Biological Information

Background Information:

Cytochrome P450 (CYP) inhibition is one of the most common types of drug-drug interactions (DDI) and can be exhibited in either a reversible or time-dependent manner. This assay is designed to determine if a test compound is an irreversible, time-dependent inhibitor of CYP2C19 in human liver microsomes

No. of Assays on Panel:

2

Assays on Panel:

Family

CYP450

Name

Item

2546

Protein

CYP2C19

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

2547

Protein

CYP2C19

Organism

Human

Assay Sub Type

Enzymatic

Family:

CYP450

Sub Family:

CYP2

Protein Name:

CYP2C19

Uniprot Number:

P33261

Gene Name:

CYP2C19

Gene ID:

1557

Gene Aliases:

P450IIC19|CPCJ

Organism:

Human

Construct Details:

Microsomes

Tissue:

Liver

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Enzymatic

Functional Mode:

Antagonist

Detection Method:

HPLC-MS/MS

Measured Response:

Peak Area Response

Testing Information

Substrate:

omeprazole

Test Concentration / Dose:

Assay is performed with each concentration tested using 2 replicate(s)

Test Sample Requirements:

Minimum for 1) Screen: 100 μl of 10 mM stock -OR- 1 to 2 mg (pre-weighed). 2) Dose Response: 250 μl of 10 mM stock -OR- 1.5 to 2 mg (pre-weighed).

Turnaround Time

Standard:

10 Business Days

Additional Information

Brand:

Cerep

Testing Location:

USA - St Charles, MO

RELATED SOLUTIONS

Item: 390
Item: 1184
Item: 1647
Item: 1772
Item: 2546
Item: 2547